Plasmacytoid pre-dendritic cells (pDC): from molecular pathways to function and disease association S Alculumbre, S Raieli, C Hoffmann, R Chelbi, FX Danlos, V Soumelis Seminars in cell & developmental biology 86, 24-35, 2019 | 62 | 2019 |
A novel MYCN-specific antigene oligonucleotide deregulates mitochondria and inhibits tumor growth in MYCN-amplified neuroblastoma L Montemurro, S Raieli, S Angelucci, D Bartolucci, C Amadesi, S Lampis, ... Cancer research 79 (24), 6166-6177, 2019 | 31 | 2019 |
TLR1/2 orchestrate human plasmacytoid predendritic cell response to gram+ bacteria S Raieli, C Trichot, S Korniotis, L Pattarini, V Soumelis PLoS biology 17 (4), e3000209, 2019 | 28 | 2019 |
MYCN Drives a Tumor Immunosuppressive Environment Which Impacts Survival in Neuroblastoma S Raieli, D Di Renzo, S Lampis, C Amadesi, L Montemurro, A Pession, ... Frontiers in Oncology 11, 625207, 2021 | 27 | 2021 |
MYCN impact on high-risk neuroblastoma: from diagnosis and prognosis to targeted treatment D Bartolucci, L Montemurro, S Raieli, S Lampis, A Pession, P Hrelia, ... Cancers 14 (18), 4421, 2022 | 25 | 2022 |
The MYCN inhibitor BGA002 restores the retinoic acid response leading to differentiation or apoptosis by the mTOR block in MYCN-amplified neuroblastoma S Lampis, S Raieli, L Montemurro, D Bartolucci, C Amadesi, S Bortolotti, ... Journal of Experimental & Clinical Cancer Research 41 (1), 160, 2022 | 13 | 2022 |
ADA2 is a lysosomal DNase regulating the type-I interferon response OK Greiner-Tollersrud, V Boehler, E Bartok, M Krausz, A Polyzou, ... bioRxiv, 2020.06. 21.162990, 2020 | 12 | 2020 |
Antigene MYCN Silencing by BGA002 Inhibits SCLC Progression Blocking mTOR Pathway and Overcomes Multidrug Resistance S Bortolotti, S Angelucci, L Montemurro, D Bartolucci, S Raieli, S Lampis, ... Cancers 15 (3), 990, 2023 | 3 | 2023 |
TLR2/1 orchestrate human plasmacytoid dendritic cells response to Gram+ bacteria S Raieli Université Paris-Saclay, 2016 | | 2016 |
TLR2/1 Orchestrent la réponse de les cellules dendritiques plasmacytoïdes humaines à les bactéries Gram+ S Raieli Université Paris-Saclay (ComUE), 2016 | | 2016 |
TLR2 S Raieli | | 2016 |